KinetoChem LLC is a US-based company which manufactures high purity synthetic cannabinoids for all stages of research. We offer Active Pharmaceutical Ingredients (APIs) for pre-clinical, clinical, and consumer goods with various quantities available (milligram, gram, and kilogram). Our facility and manufacturing processes meet all state and federal regulatory requirements including DEA Schedule I licensing for Analysis, Bulk Manufacturing, and Export.
Innocan Pharma is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”) with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. The Company’s operations and research and development activities are based in Israel.
Innocan Pharma’s business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) the research and development of CBD loaded exosomes (“CLX”); (ii) the research and development of the use of CBD loaded liposomes; and (iii) the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products.
Innocan Pharma is led by a multi-disciplinary management and R&D team, headed by:Iris Bincovich, an experienced healthcare Executive, Ron Mayron, former CEO of Teva Israel, one of the largest generic pharmaceutical companies in the world. Yoram Drucker Founder of two Nasdaq traded companies – Pluristem & Brainstorm, working with stem cells, Nir Avram, former member of the pharma innovation team at Perrigo, Prof. Hezy Barenholz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University – Jerusalem and Prof. Daniel Offen, a leading researcher specializing in Neuroscience and Exosome technology, Head of the Department of Human Molecular Genetics and Biochemistry at Tel Aviv University.
The ICC Group is a well-respected provider of full-service engineering and design-build services, including automation, Smart 3D design, greenfield construction, and capacity expansion for process-driven industrial clients in liquid manufacturing, chemical, pharmaceutical, petrochemical, brewing and distilling, FMCG, and cannabis industries.
Our team has extensive experience and a proven track record implementing smart and successful operational solutions involving engineering and mass production around the world.
ICC has a long history of building its business by working with a deep portfolio of repeat clients that are some of the most respected companies throughout the world.
Purisys is a leading supplier of active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO) services, and pharmaceutical reference materials. Its 17,000-square-foot manufacturing facility and innovation center in Athens, Georgia is staffed by scientists and other professionals who have decades of experience in complex high-barrier custom synthetic chemistry. Purisys’ expertise in specialty and DEA-scheduled products, including cannabinoid and other controlled substances for registered pharmaceutical applications, is complemented by its extensive regulatory filing experience and know-how to produce dozens of APIs across multiple categories and indications. The company offers a fully operational global supply chain and exports to over 30 countries with full international regulatory compliance. Purisys’ CDMO services are designed to support the development of custom APIs for a wide range of clinical and niche commercial applications, linking product development services, analytical support, and manufacturing in an integrated process. Purisys’ thriving reference standards business stocks a catalog of more than 250 commercial reference standards including structural elucidation and comprehensive analytical data. It also offers custom reference standard synthesis services to support customers’ developmental and commercial needs.
To learn more about Purisys’ products and services, visit www.purisys.com
NJ Laboratories provides expert analytical chemistry & microbiology testing for the pharmaceutical, nutraceutical, dietary supplement, cosmetic, and cannabis/CBD industries. We are an FDA, DEA, registered & inspected, and ISO/IEC 17025:2017 accredited contract laboratory testing to exacting CGMP standards. Our team of scientists build upon our quality legacy, continually developing and validating methods for raw materials and finished products testing – established upon our founding over 80 years ago.
To learn more about Purisys’ products and services, visit www.njlabs.com
Kare Chemical Technologies Inc. (Kare) is a chemical and pharmaceutical technology company located in Ontario, Canada. The company is the global leader and specialist in the use of catalysis for the commercial manufacture of cannabinoids. Kare develops and owns novel compositions of matter precursors that can be converted into single component cannabinoids that are isolated in high chemical and chiral purity under mild conditions. Cannabinoid products include CBD, THC, CBDV, THCV, CBDP, THCP, CBN and many more.
To learn more about Kare’s products and services, visit www.karechem.com